FindTrial
Sign In

Serum C peptide and Insulin profiles in newly diagnosed Diabetes Mellitus in young adults

Study of serum C-peptide levels and Insulin Assay in newly diagnosed Diabetes Mellitus patients aged 18 to 35 years - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099946
Enrollment
80
Registered
2025-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E139- Other specified diabetes mellituswithout complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Serum C-peptide and Insulin assay estimation: Newly diagnosed diabetes mellitus patients aged 18 to 35 years

Sponsors

Dr Dhivya Anushya N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are newly diagnosed with diabetes mellitus of age group 18 to 35 years according to ADA 2025 Criteria

Exclusion criteria

Exclusion criteria: Type 1 and Type 2 Diabetes patients who are on treatment Pregnancy

Design outcomes

Primary

MeasureTime frame
Evaluating the impact of C-peptide levels on beta-cell function and insulin secretionTimepoint: 9 months—

Secondary

MeasureTime frame
1 Determining Insulin Requirements 2 Monitoring Disease ProgressionTimepoint: 9 months—

Countries

India

Contacts

Public ContactDr C K Vijayasamundeeswari

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals

drvijimani@gmail.com9894894445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026